Evaluation of the criteria for renewal of LHRH agonists in patients with prostate cancer: results of the ANAREN Study

• Main Authors: Jesús Calleja-Escudero (Author), Víctor Barrondo (Author), Andrés Rodriguez-Alonso (Author), Francisco Gómez-Veiga (Author), Joan Bestard (Author), Antonio Gómez-Caamaño (Author), Anne-Sophie Grandoulier (Author), Maria Pérez-Sampietro (Author), Venancio Chantada-Abal (Author), Raúl Poza de Celis (Author), on behalf of ANAREN Study Group (Author)
• Format: Book
• Published: BioExcel Publishing Ltd, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Injectable extended-release formulations of luteinizing hormone-releasing hormone agonists (LHRHa) have simplified the treatment of prostate cancer with a satisfactory level of androgen castration. This study aims to determine the percentage of patients whose initial LHRHa prescription...